Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-28

FDA Approved: GALANTAMINE — Supplemental Application (Slate Run Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for GALANTAMINE from Slate Run Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Galantamine (galantamine)

Snippet

SUPPL AP for GALANTAMINE (GALANTAMINE)